Details

Autor(en) / Beteiligte

• Huynh, Tien-Phat V
• Wang, Chao
• Tran, Ainsley C
• Tabor, G. Travis
• Mahan, Thomas E
• Francis, Caroline M
• Finn, Mary Beth
• Spellman, Rebecca
• Manis, Melissa
• Tanzi, Rudolph E
• Ulrich, Jason D
• Holtzman, David M

Titel

Lack of hepatic apoE does not influence early A[beta] deposition: observations from a new APOE knock-in model

Ist Teil von

• Molecular neurodegeneration, 2019-10, Vol.14 (1)

Ort / Verlag

BioMed Central Ltd

Erscheinungsjahr

2019

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• Background The apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-onset Alzheimer disease (AD). ApoE is produced by both astrocytes and microglia in the brain, whereas hepatocytes produce the majority of apoE found in the periphery. Studies using APOE knock-in and transgenic mice have demonstrated a strong isoform-dependent effect of apoE on the accumulation of amyloid-[beta] (A[beta]) deposition in the brain in the form of both A[beta]-containing amyloid plaques and cerebral amyloid angiopathy. However, the specific contributions of different apoE pools to AD pathogenesis remain unknown. Methods We have begun to address these questions by generating new lines of APOE knock-in (APOE-KI) mice ([epsilon]2/[epsilon]2, [epsilon]3/[epsilon]3, and [epsilon]4/[epsilon]4) where the exons in the coding region of APOE are flanked by loxP sites, allowing for cell type-specific manipulation of gene expression. We assessed these mice both alone and after crossing them with mice with amyloid deposition in the brain. Using biochemical and histological methods. We also investigated how removal of APOE expression from hepatocytes affected cerebral amyloid deposition. Results As in other APOE knock-in mice, apoE protein was present predominantly in astrocytes in the brain under basal conditions and was also detected in reactive microglia surrounding amyloid plaques. Primary cultured astrocytes and microglia from the APOE-KI mice secreted apoE in lipoprotein particles of distinct size distribution upon native gel analysis with microglial particles being substantially smaller than the HDL-like particles secreted by astrocytes. Crossing of APP/PS1 transgenic mice to the different APOE-KI mice recapitulated the previously described isoform-specific effect ([epsilon]4 > [epsilon]3) on amyloid plaque and A[beta] accumulation. Deletion of APOE in hepatocytes did not alter brain apoE levels but did lead to a marked decrease in plasma apoE levels and changes in plasma lipid profile. Despite these changes in peripheral apoE and on plasma lipids, cerebral accumulation of amyloid plaques in APP/PS1 mice was not affected. Conclusions Altogether, these new knock-in strains offer a novel and dynamic tool to study the role of APOE in AD pathogenesis in a spatially and temporally controlled manner. Keywords: apoE, Apolipoprotein E, Amyloid, A[beta], apoE particle, Cre-loxP, Albumin, Mouse model